Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to validate a french version of the 5 minutes version of the Montreal Cognitive Assessment as compared to the french full version of this test.


Clinical Trial Description

The Montreal Cognitive Assessment (MOCA) is a test used to detect cognitive impairments. This test is available in different languages including french. A short version (the 5 minutes MOCA) has also been validated through a phone call use that allows to develop some epidemiological approaches. Nevertheless, this short version has not been validated in french.

The main aim of the study is to validate the french translation of the short version of the MOCA as compared the the full french version of the test.

To validate the short version, several groups of subjects will be included : healthy subjects, Alzheimer disease patients, Parkinson or Huntington diseases patients as well as diabetic patients.

The inclusion of both healthy subjects and patients with different types of cognitive impairments will allow to validate the short version of the test.

All subjects and patients will first be submitted to the full version of the MOCA during a face to face procedure. Thirty to forty days later, they will be submitted to the short version of the test through a phone call performed by an independent rater.

Subgroups of healthy subjects and patients will also be used to determine the test-retest and inter-rater reliability of the short version of the MOCA. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03232697
Study type Interventional
Source University Hospital, Lille
Contact
Status Completed
Phase N/A
Start date July 12, 2017
Completion date August 8, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05839405 - Food Allergy in the Brain
Completed NCT04873804 - The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults N/A
Completed NCT04118985 - Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease N/A
Completed NCT03736577 - Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review N/A
Completed NCT03624621 - Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM) N/A
Active, not recruiting NCT03469089 - Touchscreen-based Cognitive Tests in Healthy Volunteers Phase 1
Completed NCT03227653 - Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
Completed NCT04809974 - Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID) Phase 4
Not yet recruiting NCT06026098 - Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts N/A
Completed NCT04246736 - A Proactive Intervention Promoting Strategies for Sleep and Recovery in Nurses N/A
Not yet recruiting NCT06073886 - Personalized Brain Stimulation to Treat Chronic Concussive Symptoms Phase 2
Recruiting NCT06066619 - Can Cranberry Juice Enhance the Cognition Accuracy and Alleviate Negative Mental Consequences During Multitasking? N/A
Recruiting NCT05400512 - Cognitive Enhancement in Depression (The COG-D Study) N/A
Completed NCT05793736 - Prevention of Long Covid Syndrome N/A
Recruiting NCT05162651 - Effect of Extended Cannabis Abstinence on PTSD Symptoms N/A
Withdrawn NCT04423471 - Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
Completed NCT03246269 - Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
Not yet recruiting NCT03353337 - A Study of Aerobic Exercise for Patients With Bipolar Disorder N/A
Completed NCT04499560 - The Effects of a Nutrition Supplement on Health Related Quality of Life N/A
Recruiting NCT04033510 - Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)